Vicky W. Zhang

Vicky W. Zhang is a seasoned finance professional currently serving as the Chief Financial Officer at IGNIS Therapeutics (Shanghai) Co., Ltd since April 2025. With a background that includes substantial experience as an angel investor since August 2014, Vicky has made notable investments in start-ups, such as Green Africa, addressing unmet needs in developing countries. Previously, Vicky held the position of Chief Financial Officer at Adlai Nortye Biopharma Co., Ltd from June 2021 to December 2024, leading the company's transformation into a publicly listed entity. Additionally, Vicky worked at Goldman Sachs from November 2015 to June 2021 as an Executive Director in investment banking, focusing on healthcare, technology, and consumer retail sectors, and has experience as an investment banking analyst at Nomura International plc. Vicky holds a Master of Science in Financial Economics from the University of Oxford.